GHK-Cu was discovered at UCSF in 1973. A published clinical trial documented hair regrowth in 100% of participants. For decades it sat in academic journals. Now independent research labs are making it available at clinical concentration to the public. Here's how it works:
In 2016, Lee et al. published a peer-reviewed study in the Annals of Dermatology. 45 men. 6 months. GHK-Cu at clinical concentration. Every participant experienced measurable hair regrowth. The compound isn't new — your body produced it naturally in your 20s. What's new is access to it at clinical grade.
Clinical-grade GHK-Cu available now — Get GHK-Cu From FORMERA LABS →
Clinical-grade GHK-Cu available now — Get GHK-Cu From FORMERA LABS →
Research shows it reactivates follicle stem cells, promotes new blood vessel formation to the scalp, and rebuilds the collagen structure around each follicle. It's not forcing growth artificially — it's restoring the conditions that made growth happen naturally when you were younger.
No. The Rogaine shed happens because Minoxidil forces a vascular cycle reset. GHK-Cu restores the cellular environment — a different mechanism entirely. No shedding phase has been documented in clinical research.
A 2023 peer-reviewed study in Bioactive Materials concluded GHK-Cu is 'more effective than minoxidil and finasteride with minimal side effects.' The difference is mechanism — it addresses root cause rather than symptom.
Most men notice changes in texture and density around 8–12 weeks. The published clinical trial showed measurable results at 6 months with every single participant experiencing regrowth. Individual timing varies based on follicle stage.
Third-party tested · Certificate of Analysis included · Clinical grade concentration
Get GHK-Cu →